Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
L 152804
Cat. No.:
OB0425LY-023
Appearance:
Solid
Purity:
99.48%
Identity:
Confirmed by LC-MS.
Size:
Add to basket
Product Overview
Description:
L 152804 is a highly selective non-peptide antagonist targeting the NPY Y(5) receptor. It is related to food intake and energy expenditure.
Synonyms:
6508-43-6; L-152,804; L 152804; L-152804; 2-(3,3-Dimethyl-1-oxo-2,3,4,9-tetrahydro-1H-xanthen-9-yl)-5,5-dimethylcyclohexane-1,3-dione; 2-(3,3-Dimethyl-1-oxo-4,9-dihydro-2H-xanthen-9-yl)-5,5-dimethylcyclohexane-1,3-dione; 5,5-Dimethyl-2-(2,3,4,9-tetrahydro-3,3-dimethyl-1oxo-1H-xanthen-9-yl)-1,3-cyclohexanedione
CAS No.:
6508-43-6
Compound CID:
3765615
Formula:
C23H26O4
Formula Weight:
366.45
Specification
Target:
Neuropeptide Y receptor
Pathway:
GPCR/G protein; Neuronal signaling
Solubility:
DMSO
Storage:
Storage at -20°C.
Applications:
L 152804 can be used to study fat metabolism, insulin sensitivity and potential applications for the treatment of diabetes.
